In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

November 15, 2022
Walmart Confirms $3B Deal Over Pharmacies' Opioid Sales

Walmart officially revealed a $3.1 billion offer Tuesday aimed at ending thousands of lawsuits accusing its nationwide pharmacy network of fueling America's deadly crisis of opioid abuse, echoing similar settlements involving CVS Pharmacy and Walgreens.
November 14, 2022
6th Circ. Allows Opioid Judge's 'Unusual' Bellwether Approach

An Ohio federal judge's policy of permitting local governments to overhaul bellwether complaints in multidistrict opioid litigation without facing a firm cutoff date is "unconventional" and "unusual" but not unacceptable, the Sixth Circuit ruled, rebuffing a large pharmacy chain's challenge.
November 09, 2022
Walgreens Faces $10B Opioid Trial Threat Despite $5B Deal

New Mexico and Walgreens have submitted written closing arguments in the Land of Enchantment's opioid trial, and the state said it wants nearly $10 billion in damages — twice as much as Walgreens offered last week to settle opioid litigation across the entire country.
November 04, 2022
SF-Walgreens Opioid Trial Called Off Amid Settlement Talks

Just days after Walgreens announced its $5 billion tentative settlement of nationwide opioid litigation, a California federal judge called off Monday's remedies trial in connection with an August decision that found the pharmacy giant liable for San Francisco's struggles with rampant opioid abuse.
November 02, 2022
After Pharmacy Deals, New Opioid Sellers In Legal 'Bull's-Eye'

Multibillion-dollar settlements with top pharmacy retailers will shift a historic barrage of opioid litigation away from the last of its early targets and toward groups of pharmaceutical sellers and advisers whose business practices and legal defenses have received little attention, according to plaintiffs counsel and court records.
November 02, 2022
CVS, Walgreens Offer $10B To End Nationwide Opioid Suits

CVS Pharmacy and Walgreens, the nation's two largest drugstore retailers, have preliminarily struck deals worth $10 billion to end thousands of lawsuits targeting their sales of prescription narcotics, the corporations and plaintiffs counsel said Wednesday.
October 27, 2022
Walgreens Says It'll Fight SF Estimate 40K Hooked On Opioids

Walgreens will challenge a California federal judge's estimate that 40,000 San Franciscans suffered from opioid addiction, the retailer told the judge on Thursday ahead of a trial to determine what damages it owes for fueling the crisis, saying the number matters because the city wants it to pay billions for treatment.
October 26, 2022
SF Details $8B Opioid Plan As Walgreens Remedy Trial Looms

San Francisco deserves $8 billion from Walgreens to alleviate the opioid epidemic's "calamitous effects," but it expects less money because the company created a problem it "cannot afford to fix," the city said Wednesday ahead of an imminent damages trial.
October 26, 2022
Pharmacies Win Temporary Freeze Of Ohio Opioid Injunction

A federal judge on Wednesday gave CVS Pharmacy, Walgreens and Walmart a temporary reprieve from business practice requirements he imposed following a trial that found the pharmacy chains liable for problems associated with prescription painkiller addiction in two Ohio counties.
October 18, 2022
NM Opioid Case Against Walgreens 'Easy,' AG Says In Finale

New Mexico's attorney general's office closed out an opioid bench trial against Walgreens on Tuesday with a declaration to the judge that the pharmacy giant has "made it easy for you with its admissions" at trial about how it distributed and dispensed the powerful narcotics.

← Previous
1
2
3
4
5
6
7
8
9
10
…
Next →